The US FDA has approved the first biosimilar version of AstraZeneca/Alexion’s Soliris therapy for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

we spoke with cardiologists to find the most accurate and user-friendly options on the market -- all FDA-approved. Ideally, everyone should, according to Dr. Mary Branch, a cardiologist at Cone ...

But this was not a clinical study, notes Norman Edelman, MD, chief medical officer of the American Lung Association, one of the organizations that has called for an FDA ban on e-cigarettes.

Climate change may be a significant predictor of adverse cardio-kidney-metabolic heath and could serve to identify areas to target public health interventions and more, researchers reported. Locum ...

Healthline asked Janelle Duah, MD, assistant professor of medicine at ... the Food and Drug Administration (FDA) doesn’t approve and warns against consuming compounded versions of injectable ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.